Skip to main content
. 2020 Feb 5;19(4):2943–2949. doi: 10.3892/ol.2020.11368

Table II.

The analysis of the responses of patients who received GC chemotherapy.

Response Number of patients Response rate (%)
CR   7 11.5
PR 20 32.8
SD 20 32.8
PD 14 22.9
Overall response rate (CR+PR) 27 44.3

CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; GC, gemcitabine and cisplatin.